Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.

This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...

Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

GLP-1 drugs like Ozempic, while effective for significant weight loss and reducing chronic disease risk, are associated with ...

Many people experience a serious return of appetite, cravings and weight after coming off Ozempic, and having read far too ...

In a world flooded with quick-fix diets, unsafe pills, and unrealistic workout programs, SlimJaro emerges as a reliable, ...

Novo Nordisk faces a suit claiming it failed to warn users of Ozempic of the danger of blindness. The suit is brought by a ...

Dr William Li, whose book Eat to Beat Your Diet is a New York Times bestseller, says the most dangerous type of fat is ...

Trending weight loss drugs such as Ozempic and Wegovy may be highly effective at tackling obesity, but are they also carrying ...

Tess Holliday is never one to shy away from clapping back at body-shamers on social media. On Tuesday, April 22, the ...

Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.